Proto-oncogene tyrosine-protein kinase LCK

Description:

Description
  • Accession: P06240
  • Swissprot: LCK_MOUSE
  • Organism: Mus musculus
  • Gene: Lck
  • Target class: Kinase

Drug Relations:

dasatinib
A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB. Bioactivity details MOA